ArticleThe Australian & New Zealand journal of obstetrics & gynaecology2026
Benchmarking Cervical Cancer Care Pathways-Measuring Timelines and Identifying Factors Associated With Delay for Women Undergoing Definitive Radiotherapy in New South Wales, Australia.
Article in The Australian & New Zealand journal of obstetrics & gynaecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiagnosis and management of cervical cancer require multiple investigations and specialist reviews, with delays leading to increased mortality and morbidity. Australia's Optimal Care Pathways (OCPs) recommends that patients with suspected diagnosis of cervical cancer should have their diagnostic processes completed within certain timeframes. Despite these guidelines, there is currently no benchmarking of cervical cancer timelines.
aimsThis study aims to benchmark cervical cancer care and identify factors associated with delay. MATERIALS AND
methodsPatients who underwent radiotherapy for Stage I-III cervical cancer between 2015 and 2024 at a major tertiary hospital in New South Wales (NSW) were included in the study. This hospital provides centralised gynae-oncology care for all women in three NSW local health districts. Patients were stratified based on age, stage of disease, level of rurality and level of socioeconomic advantage/disadvantage. Each step of the diagnostic timeline was benchmarked against the OCPs. Univariate and multivariate logistic regression were performed to detect factors associated with delays.
resultsThe study cohort comprised 155 patients. Under 60% of women were managed in-line with the OCPs recommended timelines. 86% (n = 19/22) of women from the least disadvantaged socio-economic tertile saw a gynae-oncology specialist within the recommended timeframe compared to 47% (36/76) from the most disadvantaged socio-economic tertile (OR: 6.24, CI: 1.60-24.27, p = 0.008).
conclusionsRecommended diagnostic timelines were not met in a significant proportion of women. Women from the greatest levels of socioeconomic disadvantage were more likely to face delays. Benchmarking processes need to be implemented in cancer care, to ensure equity in outcomes/processes for all patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.